MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2019)

MeiraGTx Holdings (MGTX) reported Tax Provisions of -$338670.0 for Q3 2019, down 270.58% quarter-over-quarter from -$91390.0 in Q2 2019.

MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2019) Analysis & Trends

MeiraGTx Holdings has reported Tax Provisions for 2 years, with the latest figure at -$338670.0 in Q3 2019.

For the quarter ending Q3 2019, Tax Provisions changed N/A year-over-year to -$338670.0; the trailing twelve-month figure through Sep 2019 stood at -$904451.0 (changed N/A YoY), and the FY2018 full-year result was -$474391.0, changed N/A from the prior year.
Tax Provisions for Q3 2019 stood at -$338670.0, down from -$91390.0 in the prior quarter.
The five-year high for Tax Provisions was -$91390.0 in Q2 2019, with the low at -$474391.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-11.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	216,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-859,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	221.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	MeiraGTx Holdings	910.47 Mn	844.54 Mn	74.89 Mn	-

Download Data